150 related articles for article (PubMed ID: 26472031)
1. Targeting RIPK1,2,3 to combat inflammation.
Bullock AN; Degterev A
Oncotarget; 2015 Oct; 6(33):34057-8. PubMed ID: 26472031
[No Abstract] [Full Text] [Related]
2. HIV-1 protease cleaves the serine-threonine kinases RIPK1 and RIPK2.
Wagner RN; Reed JC; Chanda SK
Retrovirology; 2015 Aug; 12():74. PubMed ID: 26297639
[TBL] [Abstract][Full Text] [Related]
3. Pathogen-mediated proteolysis of the cell death regulator RIPK1 and the host defense modulator RIPK2 in human aortic endothelial cells.
Madrigal AG; Barth K; Papadopoulos G; Genco CA
PLoS Pathog; 2012; 8(6):e1002723. PubMed ID: 22685397
[TBL] [Abstract][Full Text] [Related]
4. RIPK1 and RIPK3: critical regulators of inflammation and cell death.
Newton K
Trends Cell Biol; 2015 Jun; 25(6):347-53. PubMed ID: 25662614
[TBL] [Abstract][Full Text] [Related]
5. Synthetic Biology Reveals the Uniqueness of the RIP Kinase Domain.
Chirieleison SM; Kertesy SB; Abbott DW
J Immunol; 2016 May; 196(10):4291-7. PubMed ID: 27045108
[TBL] [Abstract][Full Text] [Related]
6. The diverse role of RIP kinases in necroptosis and inflammation.
Silke J; Rickard JA; Gerlic M
Nat Immunol; 2015 Jul; 16(7):689-97. PubMed ID: 26086143
[TBL] [Abstract][Full Text] [Related]
7. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
[TBL] [Abstract][Full Text] [Related]
8. Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.
Wegner KW; Saleh D; Degterev A
Trends Pharmacol Sci; 2017 Mar; 38(3):202-225. PubMed ID: 28126382
[TBL] [Abstract][Full Text] [Related]
9. The Inflammatory Signal Adaptor RIPK3: Functions Beyond Necroptosis.
Moriwaki K; Chan FK
Int Rev Cell Mol Biol; 2017; 328():253-275. PubMed ID: 28069136
[TBL] [Abstract][Full Text] [Related]
10. Necroptosis and Inflammation.
Newton K; Manning G
Annu Rev Biochem; 2016 Jun; 85():743-63. PubMed ID: 26865533
[TBL] [Abstract][Full Text] [Related]
11. RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4.
Najjar M; Saleh D; Zelic M; Nogusa S; Shah S; Tai A; Finger JN; Polykratis A; Gough PJ; Bertin J; Whalen M; Pasparakis M; Balachandran S; Kelliher M; Poltorak A; Degterev A
Immunity; 2016 Jul; 45(1):46-59. PubMed ID: 27396959
[TBL] [Abstract][Full Text] [Related]
12. RIPK1 inhibits ZBP1-driven necroptosis during development.
Newton K; Wickliffe KE; Maltzman A; Dugger DL; Strasser A; Pham VC; Lill JR; Roose-Girma M; Warming S; Solon M; Ngu H; Webster JD; Dixit VM
Nature; 2016 Dec; 540(7631):129-133. PubMed ID: 27819682
[TBL] [Abstract][Full Text] [Related]
13. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
[TBL] [Abstract][Full Text] [Related]
14. Emerging Roles for RIPK1 and RIPK3 in Pathogen-Induced Cell Death and Host Immunity.
Saleh D; Degterev A
Curr Top Microbiol Immunol; 2017; 403():37-75. PubMed ID: 26385769
[TBL] [Abstract][Full Text] [Related]
15. Regulatory mechanisms of RIPK1 in cell death and inflammation.
Liu Z; Chan FK
Semin Cell Dev Biol; 2021 Jan; 109():70-75. PubMed ID: 32616439
[TBL] [Abstract][Full Text] [Related]
16. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.
Newton K; Dugger DL; Wickliffe KE; Kapoor N; de Almagro MC; Vucic D; Komuves L; Ferrando RE; French DM; Webster J; Roose-Girma M; Warming S; Dixit VM
Science; 2014 Mar; 343(6177):1357-60. PubMed ID: 24557836
[TBL] [Abstract][Full Text] [Related]
17. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis.
Rickard JA; O'Donnell JA; Evans JM; Lalaoui N; Poh AR; Rogers T; Vince JE; Lawlor KE; Ninnis RL; Anderton H; Hall C; Spall SK; Phesse TJ; Abud HE; Cengia LH; Corbin J; Mifsud S; Di Rago L; Metcalf D; Ernst M; Dewson G; Roberts AW; Alexander WS; Murphy JM; Ekert PG; Masters SL; Vaux DL; Croker BA; Gerlic M; Silke J
Cell; 2014 May; 157(5):1175-88. PubMed ID: 24813849
[TBL] [Abstract][Full Text] [Related]
18. RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis.
Kearney CJ; Cullen SP; Clancy D; Martin SJ
FEBS J; 2014 Nov; 281(21):4921-34. PubMed ID: 25195660
[TBL] [Abstract][Full Text] [Related]
19. K45A mutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo.
Shutinoski B; Alturki NA; Rijal D; Bertin J; Gough PJ; Schlossmacher MG; Sad S
Cell Death Differ; 2016 Oct; 23(10):1628-37. PubMed ID: 27258786
[TBL] [Abstract][Full Text] [Related]
20. RIPK1 and RIPK3 inhibitors: potential weapons against inflammation to treat diabetic complications.
Ke D; Zhang Z; Liu J; Chen P; Dai Y; Sun X; Chu Y; Li L
Front Immunol; 2023; 14():1274654. PubMed ID: 37954576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
